Cargando…
NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1
Breast cancer (BC) is a serious threat to women’s health worldwide. Non‐SMC condensin I complex subunit D2 (NCAPD2) is a regulatory subunit of the coagulin I complex, which is mainly involved in chromosome coagulation and separation. The clinical significance, biological behavior, and potential mole...
Autores principales: | He, Jinsong, Gao, Rui, Yang, Jianbo, Li, Feng, Fu, Yang, Cui, Junwei, Liu, Xiaoling, Huang, Kanghua, Guo, Qiuyi, Zhou, Zihan, Wei, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986070/ https://www.ncbi.nlm.nih.gov/pubmed/35348268 http://dx.doi.org/10.1111/cas.15347 |
Ejemplares similares
-
NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
por: Jing, Zuolei, et al.
Publicado: (2022) -
NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden
por: Li, Zihao, et al.
Publicado: (2023) -
Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers
por: Dong, Xiaoying, et al.
Publicado: (2023) -
Progress in the application of organoids to breast cancer research
por: Yang, Liping, et al.
Publicado: (2020) -
ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1
por: Shao, Zhuo, et al.
Publicado: (2022)